<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2025-359</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9411</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЗАБОЛЕВАНИЯ КОЖИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DERMAL DISEASES</subject></subj-group></article-categories><title-group><article-title>Хронические раны на фоне аутоиммунных заболеваний: взгляд дерматолога</article-title><trans-title-group xml:lang="en"><trans-title>Chronic wounds in patients with underlying autoimmune diseases: A dermatological point of view</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0824-8444</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебедева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedeva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лебедева Екатерина Владимировна - врач-дерматолог.</p><p>119071, Москва, Ленинский проспект, д. 17</p></bio><bio xml:lang="en"><p>Ekaterina V. Lebedeva – Dermatologist.</p><p>17, Leninskiy Ave., Moscow, 119071</p></bio><email xlink:type="simple">dr_e.lebedeva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2642-9126</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Радионова</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Radionova</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Радионова Екатерина Евгеньевна - к.м.н., заведующая отделением №0904 стационара.</p><p>119071, Москва, Ленинский проспект, д. 17</p></bio><bio xml:lang="en"><p>Ekaterina E. Radionova - Cand. Sci. (Med.), Head of Department No. 0904 of the Hospital.</p><p>17, Leninskiy Ave., Moscow, 119071</p></bio><email xlink:type="simple">radionova.ekat@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4887-284X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денисова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денисова Елена Валерьевна - к.м.н., заместитель заведующего филиалом по медицинской части, Московский НПЦ дерматовенерологии и косметологии; старший научный сотрудник, Центр теоретических проблем физико-химической фармакологии.</p><p>119071, Москва, Ленинский проспект, д. 17; 109029, Москва, Средняя Калитниковская ул., д. 30</p></bio><bio xml:lang="en"><p>Elena V. Denisova - Cand. Sci. (Med.), Deputy Head of the Branch for Medical Affairs, Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; Senior Research Fellow, Center for Theoretical Problems of Physico-Chemical Pharmacology of the RAS.</p><p>17, Leninskiy Ave., Moscow, 119071; 30, St. Srednyaya Kalitnikovskaya, Moscow, 109029</p></bio><email xlink:type="simple">evdenissova@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6583-0318</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корсунская</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Korsunskaya</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Корсунская Ирина Марковна - д.м.н., профессор, заведующая лабораторией.</p><p>109029, Москва, ул. Средняя Калитниковская, д. 30</p></bio><bio xml:lang="en"><p>Irina M. Korsunskaya - Dr. Sci. (Med.), Professor, Head of Laboratory.</p><p>30, St. Srednyaya Kalitnikovskaya, Moscow, 109029</p></bio><email xlink:type="simple">marykor@bk.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Московский научно-практический центр дерматовенерологии и косметологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Московский научно-практический центр дерматовенерологии и косметологии; Центр теоретических проблем физико-химической фармакологии Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; Center for Theoretical Problems of Physico-Chemical Pharmacology of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Центр теоретических проблем физико-химической фармакологии Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Center for Theoretical Problems of Physico-Chemical Pharmacology of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2025</year></pub-date><volume>0</volume><issue>14</issue><fpage>102</fpage><lpage>106</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лебедева Е.В., Радионова Е.Е., Денисова Е.В., Корсунская И.М., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Лебедева Е.В., Радионова Е.Е., Денисова Е.В., Корсунская И.М.</copyright-holder><copyright-holder xml:lang="en">Lebedeva E.V., Radionova E.E., Denisova E.V., Korsunskaya I.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9411">https://www.med-sovet.pro/jour/article/view/9411</self-uri><abstract><p>Более чем у 20% пациентов с хроническими ранами имеется аутоиммунное заболевание. Среди дерматологических патологий, связанных с хроническими язвами, особое место занимают аутоиммунные пузырные дерматозы. Без рационального ухода раневые поверхности в данной группе пациентов быстро инфицируются. Кроме того, лечение язв у пациентов с пузырными дерматозами является довольно сложной задачей, поскольку даже минимальная травма кожи при перевязках может привести к разрастанию язвенного дефекта. В связи с чем кажется интересным клинический случай пациентки с диагнозом «Листовидная пузырчатка с сопутствующим быстропрогрессирующим рассеянным склерозом», получающей биологическую терапию. Основная жалоба на хронические язвенные дефекты в области межягодичной складки, сохраняющиеся в течение длительного периода. Помимо стандартной терапии листовидной пузырчатки пациентке применялась альгинатная повязка с серебром экстра LUOFUCON (ЛУОФУКОН) в течение 3 нед. со сменой повязки каждые 7 дней. На фоне чего к 21-му дню наблюдалась практически полная эпителизация раневой поверхности. Данный случай свидетельствует о необходимости уделять должное внимание гигиене ран, особенно в случаях труднозаживающих язв. Использование антимикробных повязок, наряду с санацией раневой поверхности, позволяет эффективно бороться с инфекцией. Альгинатные повязки впитывают раневой экссудат и поддерживают влажную среду, что вместе с мощным антибактериальным действием улучшает микросреду раны и способствует ее эпителизации. При этом повязки не прилипают к ране, не травмируют ее при перевязках, что особенно важно у пациентов с буллезными дерматозами.</p></abstract><trans-abstract xml:lang="en"><p>Over 20% of patients with chronic wounds have an autoimmune disease. Bullous autoimmune dermatoses hold a special place among the dermatological pathologies associated with chronic ulcers, Wound surfaces in this group of patients quickly become infected without prudent care. Besides, the treatment of ulcers in patients with bullous dermatoses is quite a challenging task, as even minimal skin injury during dressing changes can lead to the development of an ulcer defect. In this regard, a clinical case report of a female patient diagnosed with “pemphigus foliaceus with concomitant rapidly progressive multiple sclerosis” receiving biological therapy appears to have interesting features. The main complaint included chronic ulcerous defects in the intergluteal fold area, which persisted for a long period. In addition to standard therapy for pemphigus foliaceus, the female patient’s wound was treated with LUOFUCON extra silver alginate dressing for 3 weeks, which was changed every 7 days. During the therapy, almost complete epithelialization of the wound surface was achieved by day 12. This case demonstrates the need to pay careful attention to wound hygiene, especially in cases of hard-to-heal ulcers. The antimicrobial dressings, along with the sanitation of the wound surface, can effectively combat infection. Alginate dressings absorb wound fluid and maintain a moist environment, which, together with a powerful antibacterial effect, improves the wound microenvironment and promotes faster epithelialization. At the same time, the dressings neither stick to the wound bed, nor injure it during dressing changes, which is especially important in patients with bullous dermatoses.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>аутоиммунные заболевания</kwd><kwd>буллезные дерматозы</kwd><kwd>язвы</kwd><kwd>гигиена ран</kwd><kwd>раневые повязки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>autoimmune disease</kwd><kwd>bullous dermatoses</kwd><kwd>ulcers</kwd><kwd>wound hygiene</kwd><kwd>wound dressings</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Wang XT, Chu WL. Advances on the research and treatment of autoimmune disease-related chronic wounds. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022;38(6):563–568. https://doi.org/10.3760/cma.j.cn501225-20220329-00101.</mixed-citation><mixed-citation xml:lang="en">Zhang L, Wang XT, Chu WL. Advances on the research and treatment of autoimmune disease-related chronic wounds. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022;38(6):563–568. https://doi.org/10.3760/cma.j.cn501225-20220329-00101.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Patil S, Gs V, Sarode GS, Sarode SC, Khurayzi TA, Mohamed Beshir SE et al. Exploring the role of immunotherapeutic drugs in autoimmune diseases: A comprehensive review. J Oral Biol Craniofac Res. 2021;11(2):291–296. https://doi.org/10.1016/j.jobcr.2021.02.009.</mixed-citation><mixed-citation xml:lang="en">Patil S, Gs V, Sarode GS, Sarode SC, Khurayzi TA, Mohamed Beshir SE et al. Exploring the role of immunotherapeutic drugs in autoimmune diseases: A comprehensive review. J Oral Biol Craniofac Res. 2021;11(2):291–296. https://doi.org/10.1016/j.jobcr.2021.02.009.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shanmugam VK. Vasculitic diseases and prothrombotic states contributing to delayed healing in chronic wounds. Curr Dermatol Rep. 2016;5(4):270–277. https://doi.org/10.1007/s13671-016-0157-2.</mixed-citation><mixed-citation xml:lang="en">Shanmugam VK. Vasculitic diseases and prothrombotic states contributing to delayed healing in chronic wounds. Curr Dermatol Rep. 2016;5(4):270–277. https://doi.org/10.1007/s13671-016-0157-2.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Yancey KB. The pathophysiology of autoimmune blistering diseases. J Clin Invest. 2005;115:825–828. https://doi.org/10.1172/JCI200524855.</mixed-citation><mixed-citation xml:lang="en">Yancey KB. The pathophysiology of autoimmune blistering diseases. J Clin Invest. 2005;115:825–828. https://doi.org/10.1172/JCI200524855.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L. Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management. Clin Rev Allergy Immunol. 2018;54:26–51. https://doi.org/10.1007/s12016-017-8633-4.</mixed-citation><mixed-citation xml:lang="en">Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L. Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management. Clin Rev Allergy Immunol. 2018;54:26–51. https://doi.org/10.1007/s12016-017-8633-4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Vorobyev A, Ludwig RJ, Schmidt E. Clinical features and diagnosis of epidermolysis bullosa acquisita. Expert Rev Clin Immunol. 2017;13:157–169. https://doi.org/10.1080/1744666X.2016.1221343.</mixed-citation><mixed-citation xml:lang="en">Vorobyev A, Ludwig RJ, Schmidt E. Clinical features and diagnosis of epidermolysis bullosa acquisita. Expert Rev Clin Immunol. 2017;13:157–169. https://doi.org/10.1080/1744666X.2016.1221343.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sugai T, Ujiie H, Nakamura H, Kikuchi K, Iwata H, Shimizu H. Case of autoimmune intraepidermal and subepidermal blistering disease in which autoantibodies to desmoglein 1 and BP230 coexist. J Dermatol. 2019;46(6):e215-e216. https://doi.org/10.1111/1346-8138.14734.</mixed-citation><mixed-citation xml:lang="en">Sugai T, Ujiie H, Nakamura H, Kikuchi K, Iwata H, Shimizu H. Case of autoimmune intraepidermal and subepidermal blistering disease in which autoantibodies to desmoglein 1 and BP230 coexist. J Dermatol. 2019;46(6):e215-e216. https://doi.org/10.1111/1346-8138.14734.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mosselhy DA, Assad M, Sironen T, Elbahri M. Nanotheranostics: A Possible Solution for Drug-Resistant Staphylococcus aureus and their Biofilms? Nanomaterials. 2021;11(1):82. https://doi.org/10.3390/nano11010082.</mixed-citation><mixed-citation xml:lang="en">Mosselhy DA, Assad M, Sironen T, Elbahri M. Nanotheranostics: A Possible Solution for Drug-Resistant Staphylococcus aureus and their Biofilms? Nanomaterials. 2021;11(1):82. https://doi.org/10.3390/nano11010082.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Taati Moghadam M, Khoshbayan A, Chegini Z, Farahani I, Shariati A. Bacteriophages, a new therapeutic solution for inhibiting multidrugresistant bacteria causing wound infection: lesson from animal models and clinical trials. Drug Des Devel Ther. 2020;14:1867–1883. https://doi.org/10.2147/DDDT.S251171.</mixed-citation><mixed-citation xml:lang="en">Taati Moghadam M, Khoshbayan A, Chegini Z, Farahani I, Shariati A. Bacteriophages, a new therapeutic solution for inhibiting multidrugresistant bacteria causing wound infection: lesson from animal models and clinical trials. Drug Des Devel Ther. 2020;14:1867–1883. https://doi.org/10.2147/DDDT.S251171.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sweere JM, Ishak H, Sunkari V, Bach MS, Manasherob R, Yadava K et al. The Immune Response to Chronic Pseudomonas aeruginosa Wound Infection in Immunocompetent Mice. Adv Wound Care. 2020;9(2):35–47. https://doi.org/10.1089/wound.2019.1039.</mixed-citation><mixed-citation xml:lang="en">Sweere JM, Ishak H, Sunkari V, Bach MS, Manasherob R, Yadava K et al. The Immune Response to Chronic Pseudomonas aeruginosa Wound Infection in Immunocompetent Mice. Adv Wound Care. 2020;9(2):35–47. https://doi.org/10.1089/wound.2019.1039.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Secor PR, Burgener EB, Kinnersley M, Jennings LK, Roman-Cruz V, Popescu M et al. Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections. Front Immunol. 2020;11:244. https://doi.org/10.3389/fimmu.2020.00244.</mixed-citation><mixed-citation xml:lang="en">Secor PR, Burgener EB, Kinnersley M, Jennings LK, Roman-Cruz V, Popescu M et al. Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections. Front Immunol. 2020;11:244. https://doi.org/10.3389/fimmu.2020.00244.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sen CK, Mathew-Steiner SS, Das A, Sundaresan VB, Roy S. Electroceutical management of bacterial biofilms and surgical infection. Antioxid Redox Signal. 2020;33(10):713–724. https://doi.org/10.1089/ars.2020.8086.</mixed-citation><mixed-citation xml:lang="en">Sen CK, Mathew-Steiner SS, Das A, Sundaresan VB, Roy S. Electroceutical management of bacterial biofilms and surgical infection. Antioxid Redox Signal. 2020;33(10):713–724. https://doi.org/10.1089/ars.2020.8086.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Barki KG, Das A, Dixith S, Ghatak PD, Mathew-Steiner S, Schwab E et al. Electric Field Based Dressing Disrupts Mixed-Species Bacterial Biofilm Infection and Restores Functional Wound Healing. Ann Surg. 2019;269(4):756–766. https://doi.org/10.1097/SLA.0000000000002504.</mixed-citation><mixed-citation xml:lang="en">Barki KG, Das A, Dixith S, Ghatak PD, Mathew-Steiner S, Schwab E et al. Electric Field Based Dressing Disrupts Mixed-Species Bacterial Biofilm Infection and Restores Functional Wound Healing. Ann Surg. 2019;269(4):756–766. https://doi.org/10.1097/SLA.0000000000002504.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rahim K, Saleha S, Zhu X, Huo L, Basit A, Franco OL. Bacterial Contribution in Chronicity of Wounds. Microb Ecol. 2017;73(3):710–721. https://doi.org/10.1007/s00248-016-0867-9.</mixed-citation><mixed-citation xml:lang="en">Rahim K, Saleha S, Zhu X, Huo L, Basit A, Franco OL. Bacterial Contribution in Chronicity of Wounds. Microb Ecol. 2017;73(3):710–721. https://doi.org/10.1007/s00248-016-0867-9.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ganesh K, Sinha M, Mathew-Steiner SS, Das A, Roy S, Sen CK. Chronic Wound Biofilm Model. Adv Wound Care. 2015;4(7):382–388. https://doi.org/10.1089/wound.2014.0587.</mixed-citation><mixed-citation xml:lang="en">Ganesh K, Sinha M, Mathew-Steiner SS, Das A, Roy S, Sen CK. Chronic Wound Biofilm Model. Adv Wound Care. 2015;4(7):382–388. https://doi.org/10.1089/wound.2014.0587.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wu YK, Cheng NC, Cheng CM. Biofilms in Chronic Wounds: Pathogenesis and Diagnosis. Trends Biotechnol. 2019;37(5):505–517. https://doi.org/10.1016/j.tibtech.2018.10.011.</mixed-citation><mixed-citation xml:lang="en">Wu YK, Cheng NC, Cheng CM. Biofilms in Chronic Wounds: Pathogenesis and Diagnosis. Trends Biotechnol. 2019;37(5):505–517. https://doi.org/10.1016/j.tibtech.2018.10.011.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wolcott R, Fletcher J. The role of wound cleansing in the management of wounds. Wounds Int. 2014;1(1):25–30. Available at: https://woundsinternational.com/journal-articles/the-role-of-wound-cleansing-in-the-management-of-wounds.</mixed-citation><mixed-citation xml:lang="en">Wolcott R, Fletcher J. The role of wound cleansing in the management of wounds. Wounds Int. 2014;1(1):25–30. Available at: https://woundsinternational.com/journal-articles/the-role-of-wound-cleansing-in-the-management-of-wounds.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kamolz L-P, Wild T. Wound bed preparation: The impact of debridement and wound cleansing. Wound Medicine. 2013;1:44–50. https://doi.org/10.1016/j.wndm.2013.03.006.</mixed-citation><mixed-citation xml:lang="en">Kamolz L-P, Wild T. Wound bed preparation: The impact of debridement and wound cleansing. Wound Medicine. 2013;1:44–50. https://doi.org/10.1016/j.wndm.2013.03.006.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Rodeheaver GT, Ratliff CR. Wound cleansing, wound irrigation, wound disinfection. In: Krasner DL, van Rijswijk L (eds.). Chronic Wound Care: The Essentials e-Book. Malvern, PA: HMP; 2018, pp. 47–62. Available at: https://whywoundcare.s3.amazonaws.com/Files/Chapter+5.pdf.</mixed-citation><mixed-citation xml:lang="en">Rodeheaver GT, Ratliff CR. Wound cleansing, wound irrigation, wound disinfection. In: Krasner DL, van Rijswijk L (eds.). Chronic Wound Care: The Essentials e-Book. Malvern, PA: HMP; 2018, pp. 47–62. Available at: https://whywoundcare.s3.amazonaws.com/Files/Chapter+5.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Alwadani N, Fatehi P. Synthetic and lignin-based surfactants: Challenges and opportunities. Carbon Resources Conversion. 2018;1(2):126–38. https://doi.org/10.1016/j.crcon.2018.07.006.</mixed-citation><mixed-citation xml:lang="en">Alwadani N, Fatehi P. Synthetic and lignin-based surfactants: Challenges and opportunities. Carbon Resources Conversion. 2018;1(2):126–38. https://doi.org/10.1016/j.crcon.2018.07.006.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Jefferies JMC, Cooper T, Yam T, Clarke SC. Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit – a systematic review of risk factors and environmental sources. J Med Microbiol. 2012;61(8):1052–1061. https://doi.org/10.1099/jmm.0.044818-0.</mixed-citation><mixed-citation xml:lang="en">Jefferies JMC, Cooper T, Yam T, Clarke SC. Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit – a systematic review of risk factors and environmental sources. J Med Microbiol. 2012;61(8):1052–1061. https://doi.org/10.1099/jmm.0.044818-0.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Percival SL, Mayer D, Kirsner RS, Schultz G, Weir D, Roy S, Alavi A, Romanelli M. Surfactants: Role in biofilm management and cellular behaviour. Int Wound J. 2019;16(3):753–760. https://doi.org/10.1111/iwj.13093.</mixed-citation><mixed-citation xml:lang="en">Percival SL, Mayer D, Kirsner RS, Schultz G, Weir D, Roy S, Alavi A, Romanelli M. Surfactants: Role in biofilm management and cellular behaviour. Int Wound J. 2019;16(3):753–760. https://doi.org/10.1111/iwj.13093.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ge B, Wang H, Li J, Liu H, Yin Y, Zhang N, Qin S. Comprehensive Assessment of Nile Tilapia Skin (Oreochromis niloticus) Collagen Hydrogels for Wound Dressings. Mar Drugs. 2020;18(4):178. https://doi.org/10.3390/md18040178.</mixed-citation><mixed-citation xml:lang="en">Ge B, Wang H, Li J, Liu H, Yin Y, Zhang N, Qin S. Comprehensive Assessment of Nile Tilapia Skin (Oreochromis niloticus) Collagen Hydrogels for Wound Dressings. Mar Drugs. 2020;18(4):178. https://doi.org/10.3390/md18040178.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Yan C, Chen J, Wang C, Yuan M, Kang Y, Wu Z et al. Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis. Drug Deliv. 2022;29(1):214–228. https://doi.org/10.1080/10717544.2021.2023699.</mixed-citation><mixed-citation xml:lang="en">Yan C, Chen J, Wang C, Yuan M, Kang Y, Wu Z et al. Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis. Drug Deliv. 2022;29(1):214–228. https://doi.org/10.1080/10717544.2021.2023699.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Klement MR, Penrose CT, Bala A, Wellman SS, Bolognesi MP, Seyler TM. How Do Previous Solid Organ Transplant Recipients Fare After Primary Total Knee Arthroplasty? J Arthroplasty. 2016;31(3):609–15.e1. https://doi.org/10.1016/j.arth.2015.10.007.</mixed-citation><mixed-citation xml:lang="en">Klement MR, Penrose CT, Bala A, Wellman SS, Bolognesi MP, Seyler TM. How Do Previous Solid Organ Transplant Recipients Fare After Primary Total Knee Arthroplasty? J Arthroplasty. 2016;31(3):609–15.e1. https://doi.org/10.1016/j.arth.2015.10.007.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mabille C, Degboe Y, Constantin A, Barnetche T, Cantagrel A, Ruyssen-Witrand A. Infectious risk associated to orthopaedic surgery for rheumatoid arthritis patients treated by anti-TNFalpha. Joint Bone Spine. 2017;84(4):441–445. https://doi.org/10.1016/j.jbspin.2016.06.011.</mixed-citation><mixed-citation xml:lang="en">Mabille C, Degboe Y, Constantin A, Barnetche T, Cantagrel A, Ruyssen-Witrand A. Infectious risk associated to orthopaedic surgery for rheumatoid arthritis patients treated by anti-TNFalpha. Joint Bone Spine. 2017;84(4):441–445. https://doi.org/10.1016/j.jbspin.2016.06.011.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
